Richard Formica, MD
Professor of Medicine (Nephrology) and Professor of Surgery (Transplant); Director of Transplant Medicine, Internal Medicine; Director Outpatient Transplantation Service, Transplantation Center; Medical Director Adult Kidney Transplantation, Transplantation Center
Research & Publications
Biography
News
Coauthors
Selected Publications
- Physician and patient acceptance of policies to reduce kidney discardMehrotra S, Schantz K, Friedewald JJ, Ladner DP, Becker Y, Formica R, Barah M, Gu J, Gordon EJ. Physician and patient acceptance of policies to reduce kidney discard. Clinical Transplantation 2020, 34: e14054. PMID: 32738167, PMCID: PMC7929781, DOI: 10.1111/ctr.14054.
- A call to action: Feasible strategies to reduce the discard of transplantable kidneys in the United StatesStewart ZA, Shah SA, Formica RN, Kandaswamy R, Paramesh AS, Friedman J, Squires R, Cooper M, Axelrod DA. A call to action: Feasible strategies to reduce the discard of transplantable kidneys in the United States. Clinical Transplantation 2020, 34: e13990. PMID: 32621660, DOI: 10.1111/ctr.13990.
- Levothyroxine-Induced Nonischemic Cardiomyopathy in a Kidney Transplant CandidateGirone G, Cohen E, Hartell S, Formica R, Klarman S. Levothyroxine-Induced Nonischemic Cardiomyopathy in a Kidney Transplant Candidate. Annals Of Pharmacotherapy 2020, 54: 1260-1262. PMID: 32462902, DOI: 10.1177/1060028020928957.
- Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus PandemicGleeson SE, Formica RN, Marin EP. Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic. Clinical Journal Of The American Society Of Nephrology 2020, 15: cjn.04510420. PMID: 32345749, PMCID: PMC7274284, DOI: 10.2215/cjn.04510420.
- The Broader Sharing of Deceased Donor Kidneys Is an Ethical and Legal ImperativeKlarman SE, Formica RN. The Broader Sharing of Deceased Donor Kidneys Is an Ethical and Legal Imperative. Journal Of The American Society Of Nephrology 2020, 31: asn.2020020121. PMID: 32312798, PMCID: PMC7269362, DOI: 10.1681/asn.2020020121.
- Advancing American Kidney Health—New Opportunities for Collaborative CareRivara MB, Formica RN, Mehrotra R. Advancing American Kidney Health—New Opportunities for Collaborative Care. The American Journal Of Medicine 2020, 133: e335-e337. PMID: 32145208, DOI: 10.1016/j.amjmed.2020.01.036.
- Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycinAbdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M, Sherif M, Ahn KH, D’Souza D, Formica R, Southwick SM, Duman RS, Sanacora G, Krystal JH. Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology 2020, 45: 990-997. PMID: 32092760, PMCID: PMC7162891, DOI: 10.1038/s41386-020-0644-9.
- Should the United States employ free market practices to solve the hidden public health crisis of chronic kidney disease?Formica RN, Gill JS. Should the United States employ free market practices to solve the hidden public health crisis of chronic kidney disease? American Journal Of Transplantation 2019, 20: 1217-1218. PMID: 31746545, DOI: 10.1111/ajt.15718.
- Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current EraKadatz M, Gill JS, Gill J, Formica RN, Klarenbach S. Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era. Journal Of The American Society Of Nephrology 2019, 31: 218-228. PMID: 31704739, PMCID: PMC6934999, DOI: 10.1681/asn.2019070646.
- Transplantation of Kidneys from HCV Viremic Donors in the United States: A Missed Opportunity to Inform Clinical Decision Making and Health PolicyGill JS, Formica RN, Levitsky J. Transplantation of Kidneys from HCV Viremic Donors in the United States: A Missed Opportunity to Inform Clinical Decision Making and Health Policy. Journal Of The American Society Of Nephrology 2019, 30: 1778-1780. PMID: 31570540, PMCID: PMC6779353, DOI: 10.1681/asn.2019070726.
- Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRedfield RR, Jordan SC, Busque S, Vincenti F, Woodle ES, Desai N, Reed EF, Tremblay S, Zachary AA, Vo AA, Formica R, Schindler T, Tran H, Looney C, Jamois C, Green C, Morimoto A, Rajwanshi R, Schroeder A, Cascino MD, Brunetta P, Borie D. Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant. American Journal Of Transplantation 2019, 19: 3035-3045. PMID: 31257724, PMCID: PMC6899639, DOI: 10.1111/ajt.15514.
- ESKD Risk in Living Kidney Donors “Like Me”Newell KA, Formica RN. ESKD Risk in Living Kidney Donors “Like Me”. Clinical Journal Of The American Society Of Nephrology 2019, 14: 970-971. PMID: 31278113, PMCID: PMC6625628, DOI: 10.2215/cjn.06010519.
- Report of National Kidney Foundation Consensus Conference to Decrease Kidney DiscardsCooper M, Formica R, Friedewald J, Hirose R, O’Connor K, Mohan S, Schold J, Axelrod D, Pastan S. Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards. Clinical Transplantation 2018, 33: e13419. PMID: 30345720, DOI: 10.1111/ctr.13419.
- And equal access for all? The future of deceased donor kidney allocationFormica RN. And equal access for all? The future of deceased donor kidney allocation. American Journal Of Transplantation 2018, 18: 1837-1838. PMID: 29878578, DOI: 10.1111/ajt.14964.
- Solid organ transplantation of viral hepatitis C positive donor organs into viral hepatitis C negative recipientsLiapakis A, Formica RN, Levitsky J. Solid organ transplantation of viral hepatitis C positive donor organs into viral hepatitis C negative recipients. Current Opinion In Organ Transplantation 2018, 23: 257-263. PMID: 29432255, DOI: 10.1097/mot.0000000000000504.
- Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant OutcomesFaddoul G, Nadkarni GN, Bridges ND, Goebel J, Hricik DE, Formica R, Menon MC, Morrison Y, Murphy B, Newell K, Nickerson P, Poggio ED, Rush D, Heeger PS. Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes. Transplantation 2018, 102: 673-680. PMID: 29189482, PMCID: PMC6018026, DOI: 10.1097/tp.0000000000002026.
- The role of the kidney in combined liver‐kidney transplantationFormica RN. The role of the kidney in combined liver‐kidney transplantation. Liver Transplantation 2018, 24: 164-165. PMID: 29222928, DOI: 10.1002/lt.24995.
- Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting ListMiles CD, Westphal S, Liapakis A, Formica R. Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List. Current Transplantation Reports 2018, 5: 1-6. PMID: 29564203, PMCID: PMC5843696, DOI: 10.1007/s40472-018-0175-z.
- Transition probabilities between changing sensitization levels, waitlist activity status and competing-risk kidney transplant outcomes using multi-state modelingKulkarni S, Hall I, Formica R, Thiessen C, Stewart D, Gan G, Greene E, Deng Y. Transition probabilities between changing sensitization levels, waitlist activity status and competing-risk kidney transplant outcomes using multi-state modeling. PLOS ONE 2017, 12: e0190277. PMID: 29287087, PMCID: PMC5747475, DOI: 10.1371/journal.pone.0190277.
- Perspectives on the Strengths and Weaknesses of the National Kidney Allocation SystemFormica RN. Perspectives on the Strengths and Weaknesses of the National Kidney Allocation System. Clinical Journal Of The American Society Of Nephrology 2017, 12: 2056-2056. PMID: 29162591, PMCID: PMC5718280, DOI: 10.2215/cjn.08640817.
- Being Thoughtful about DesensitizationFormica RN, Kulkarni S. Being Thoughtful about Desensitization. Clinical Journal Of The American Society Of Nephrology 2017, 12: 1878-1880. PMID: 28974523, PMCID: PMC5672977, DOI: 10.2215/cjn.09000817.
- Utility of Applying Quality Assessment Tools for Kidneys With KDPI ≥80Doshi MD, Reese PP, Hall IE, Schröppel B, Ficek J, Formica RN, Weng FL, Hasz RD, Thiessen-Philbrook H, Parikh C. Utility of Applying Quality Assessment Tools for Kidneys With KDPI ≥80. Transplantation 2017, 101: 1125-1133. PMID: 27490414, PMCID: PMC5290306, DOI: 10.1097/tp.0000000000001388.
- Opportunities to Increase Availability of Deceased Donor KidneysFormica RN. Opportunities to Increase Availability of Deceased Donor Kidneys. Clinical Journal Of The American Society Of Nephrology 2017, 12: 871-873. PMID: 28546441, PMCID: PMC5460703, DOI: 10.2215/cjn.04490417.
- Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert ConferenceNewell KA, Formica RN, Gill JS, Schold JD, Allan JS, Covington SH, Wiseman AC, Chandraker A. Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference. American Journal Of Transplantation 2017, 17: 901-911. PMID: 27997071, DOI: 10.1111/ajt.14173.
- Changes in united network for organ sharing policy for simultaneous liver‐kidney allocationMerola J, Formica RN, Mulligan DC. Changes in united network for organ sharing policy for simultaneous liver‐kidney allocation. Clinical Liver Disease 2017, 9: 21-24. PMID: 30992951, PMCID: PMC6467132, DOI: 10.1002/cld.609.
- Simultaneous liver kidney transplantationFormica RN. Simultaneous liver kidney transplantation. Current Opinion In Nephrology & Hypertension 2016, 25: 577-582. PMID: 27653420, DOI: 10.1097/mnh.0000000000000260.
- Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case ReportMerola J, Yoo PS, Schaub J, Smith JD, Rodriguez-Davalos MI, Tichy E, Mulligan DC, Asch W, Formica R, Kashgarian M, Kulkarni S. Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report. Transplantation Proceedings 2016, 48: 3106-3108. PMID: 27932157, DOI: 10.1016/j.transproceed.2016.04.005.
- A critical assessment on kidney allocation systemsFormica RN. A critical assessment on kidney allocation systems. Transplantation Reviews 2016, 31: 61-67. PMID: 27919635, DOI: 10.1016/j.trre.2016.10.002.
- Eculizumab Therapy for Chronic Antibody‐Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled TrialKulkarni S, Kirkiles‐Smith N, Deng YH, Formica RN, Moeckel G, Broecker V, Bow L, Tomlin R, Pober JS. Eculizumab Therapy for Chronic Antibody‐Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial. American Journal Of Transplantation 2016, 17: 682-691. PMID: 27501352, DOI: 10.1111/ajt.14001.
- The Long‐Term Follow‐up and Support for Living Organ Donors: A Center‐Based Initiative Founded on Developing a Community of Living DonorsKulkarni S, Thiessen C, Formica RN, Schilsky M, Mulligan D, D'Aquila R. The Long‐Term Follow‐up and Support for Living Organ Donors: A Center‐Based Initiative Founded on Developing a Community of Living Donors. American Journal Of Transplantation 2016, 16: 3385-3391. PMID: 27500361, DOI: 10.1111/ajt.14005.
- Simultaneous Liver–Kidney Allocation: Let′s Not Make Perfect the Enemy of GoodFormica RN. Simultaneous Liver–Kidney Allocation: Let′s Not Make Perfect the Enemy of Good. American Journal Of Transplantation 2016, 16: 2765. PMID: 27184986, DOI: 10.1111/ajt.13873.
- Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantationAzar MM, Malinis MF, Moss J, Formica RN, Villanueva MS. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation. International Journal Of STD & AIDS 2016, 28: 447-458. PMID: 27193421, DOI: 10.1177/0956462416651528.
- Changes in Deceased Donor Kidney Transplantation One Year After KAS ImplementationStewart DE, Kucheryavaya AY, Klassen DK, Turgeon NA, Formica RN, Aeder MI. Changes in Deceased Donor Kidney Transplantation One Year After KAS Implementation. American Journal Of Transplantation 2016, 16: 1834-1847. PMID: 26932731, DOI: 10.1111/ajt.13770.
- What Is the Price of Altruism?Formica RN, Newell KA. What Is the Price of Altruism? American Journal Of Transplantation 2016, 16: 741-742. PMID: 26845497, DOI: 10.1111/ajt.13590.
- Allocating Deceased Donor Kidneys to Sensitized CandidatesFormica RN. Allocating Deceased Donor Kidneys to Sensitized Candidates. Clinical Journal Of The American Society Of Nephrology 2016, 11: 377-378. PMID: 26839236, PMCID: PMC4791831, DOI: 10.2215/cjn.13641215.
- Duration of Prophylaxis against Fungal Infection in Kidney Transplant RecipientsGuerra CM, Formica RN, Kulkarni S, Asch WS, Tichy EM. Duration of Prophylaxis against Fungal Infection in Kidney Transplant Recipients. Progress In Transplantation 2015, 25: 311-315. PMID: 26645924, DOI: 10.7182/pit2015929.
- Association Between Organ Procurement Organization Social Network Centrality and Kidney Discard and Transplant OutcomesButala NM, King MD, Reitsma W, Formica RN, Abt PL, Reese PP, Parikh CR. Association Between Organ Procurement Organization Social Network Centrality and Kidney Discard and Transplant Outcomes. Transplantation 2015, 99: 2617-2624. PMID: 26102610, PMCID: PMC4668206, DOI: 10.1097/tp.0000000000000773.
- Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant RecipientsHricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, Gibson IW, Wiebe C, Tinckam K, Bunnapradist S, Samaniego-Picota M, Brennan DC, Schröppel B, Gaber O, Armstrong B, Ikle D, Diop H, Bridges ND, Heeger PS. Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients. Journal Of The American Society Of Nephrology 2015, 26: 3114-3122. PMID: 25925687, PMCID: PMC4657844, DOI: 10.1681/asn.2014121234.
- Opting out: confidentiality and availability of an ‘alibi’ for potential living kidney donors in the USAThiessen C, Kim YA, Formica R, Bia M, Kulkarni S. Opting out: confidentiality and availability of an ‘alibi’ for potential living kidney donors in the USA. Journal Of Medical Ethics 2014, 41: 506. PMID: 25368413, DOI: 10.1136/medethics-2014-102184.
- New National Allocation Policy for Deceased Donor Kidneys in the United States and Possible Effect on Patient OutcomesIsrani AK, Salkowski N, Gustafson S, Snyder JJ, Friedewald JJ, Formica RN, Wang X, Shteyn E, Cherikh W, Stewart D, Samana CJ, Chung A, Hart A, Kasiske BL. New National Allocation Policy for Deceased Donor Kidneys in the United States and Possible Effect on Patient Outcomes. Journal Of The American Society Of Nephrology 2014, 25: 1842-1848. PMID: 24833128, PMCID: PMC4116061, DOI: 10.1681/asn.2013070784.
- The Kidney Allocation SystemFriedewald JJ, Samana CJ, Kasiske BL, Israni AK, Stewart D, Cherikh W, Formica RN. The Kidney Allocation System. Surgical Clinics Of North America 2013, 93: 1395-1406. PMID: 24206858, DOI: 10.1016/j.suc.2013.08.007.
- Cytomegalovirus Glomerulopathy and Cytomegalovirus Interstitial Nephritis on Sequential Transplant Kidney BiopsiesVichot AA, Formica RN, Moeckel GW. Cytomegalovirus Glomerulopathy and Cytomegalovirus Interstitial Nephritis on Sequential Transplant Kidney Biopsies. American Journal Of Kidney Diseases 2013, 63: 536-539. PMID: 24568687, PMCID: PMC7210789, DOI: 10.1053/j.ajkd.2013.08.021.
- Written Informed Consent for Living Kidney Donors: Practices and Compliance With CMS and OPTN RequirementsThiessen C, Kim YA, Formica R, Bia M, Kulkarni S. Written Informed Consent for Living Kidney Donors: Practices and Compliance With CMS and OPTN Requirements. American Journal Of Transplantation 2013, 13: 2713-2721. PMID: 24020884, DOI: 10.1111/ajt.12406.
- Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipientsHeavner MS, Tichy EM, Yazdi M, Formica RN, Kulkarni S, Emre S. Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients. American Journal Of Health-System Pharmacy 2013, 70: 1507-1512. PMID: 23943182, DOI: 10.2146/ajhp120783.
- Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant InjuryHricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Riggs M, Spain K, Ikle D, Bridges ND, Heeger PS, consortium F. Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury. American Journal Of Transplantation 2013, 13: 2634-2644. PMID: 23968332, PMCID: PMC3959786, DOI: 10.1111/ajt.12426.
- A renal variant of Fabry disease: A case with a novel Gal A hemizygote mutation.H Mukdsi J, Gutiérrez S, Barrón B, Novoa P, Fernández S, de Diller AB, I Torres A, Formica RN, Orías M. A renal variant of Fabry disease: A case with a novel Gal A hemizygote mutation. Journal Of Nephropathology 2012, 1: 194-7. PMID: 24475416, PMCID: PMC3886146, DOI: 10.5812/nephropathol.8123.
- A One-Day Centralized Work-up for Kidney Transplant Recipient Candidates: A Quality Improvement ReportFormica RN, Barrantes F, Asch WS, Bia MJ, Coca S, Kalyesubula R, McCloskey B, Leary T, Arvelakis A, Kulkarni S. A One-Day Centralized Work-up for Kidney Transplant Recipient Candidates: A Quality Improvement Report. American Journal Of Kidney Diseases 2012, 60: 288-294. PMID: 22571868, DOI: 10.1053/j.ajkd.2012.04.008.
- An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancersNelson WK, Formica RN, Cooper DL, Schwartz PE, Rutherford TJ. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers. Journal Of Oncology Pharmacy Practice 2012, 18: 323-332. PMID: 22331238, DOI: 10.1177/1078155211435714.
- When and how should immunosuppression be tapered for the failed renal allograft?Formica RN. When and how should immunosuppression be tapered for the failed renal allograft? Seminars In Dialysis 2011, 24: 371-373. PMID: 21801218, DOI: 10.1111/j.1525-139x.2011.00900.x.
- Combined Liver Kidney Transplantation: Critical Analysis of a Single-Center ExperienceCimsit B, Schilsky M, Moini M, Cartiera K, Arvelakis A, Kulkarni S, Formica R, Caldwell C, Taddei T, Asch W, Emre S. Combined Liver Kidney Transplantation: Critical Analysis of a Single-Center Experience. Transplantation Proceedings 2011, 43: 901-904. PMID: 21486624, DOI: 10.1016/j.transproceed.2011.02.033.
- Multidetector CT angiography in living donor renal transplantation: accuracy and discrepancies in right venous anatomyKulkarni S, Emre S, Arvelakis A, Asch W, Bia M, Formica R, Israel G. Multidetector CT angiography in living donor renal transplantation: accuracy and discrepancies in right venous anatomy. Clinical Transplantation 2011, 25: 77-82. PMID: 20070320, DOI: 10.1111/j.1399-0012.2009.01193.x.
- Renal Ultrasonography in the Evaluation of Acute Kidney Injury: Developing a Risk Stratification FrameworkLicurse A, Kim MC, Dziura J, Forman HP, Formica RN, Makarov DV, Parikh CR, Gross CP. Renal Ultrasonography in the Evaluation of Acute Kidney Injury: Developing a Risk Stratification Framework. JAMA Internal Medicine 2010, 170: 1900-1907. PMID: 21098348, DOI: 10.1001/archinternmed.2010.419.
- Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literatureCuffy MC, Singh M, Formica R, Simmons E, Abu Alfa AK, Carlson K, Girardi M, Cowper SE, Kulkarni S. Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature. Nephrology Dialysis Transplantation 2010, 26: 1099-1101. PMID: 21079195, DOI: 10.1093/ndt/gfq693.
- Accepting a donor kidney: an evaluation of patients’ and transplant surgeons’ prioritiesSolomon DA, Rabidou N, Kulkarni S, Formica R, Fraenkel L. Accepting a donor kidney: an evaluation of patients’ and transplant surgeons’ priorities. Clinical Transplantation 2010, 25: 786-793. PMID: 20964716, PMCID: PMC4846340, DOI: 10.1111/j.1399-0012.2010.01342.x.
- Significant Sirolimus and Dronedarone Interaction in a Kidney Transplant RecipientTichy EM, Medwid AJ, Mills EA, Formica RN, Kulkarni S. Significant Sirolimus and Dronedarone Interaction in a Kidney Transplant Recipient. Annals Of Pharmacotherapy 2010, 44: 1338-1341. PMID: 20484171, DOI: 10.1345/aph.1p114.
- Kidney Transplantation and HIV: Does Recipient Privacy Outweigh the Donor's Right to Information?Formica RN, Asch WS, Wagner KR, Kulkarni S. Kidney Transplantation and HIV: Does Recipient Privacy Outweigh the Donor's Right to Information? Clinical Journal Of The American Society Of Nephrology 2010, 5: 924-928. PMID: 20203162, PMCID: PMC2863980, DOI: 10.2215/cjn.06820909.
- HCV Response in Patients With End Stage Renal Disease Treated With Combination Pegylated Interferon α-2a and RibavirinHakim W, Sheikh S, Inayat I, Caldwell C, Smith D, Lorber M, Friedman A, Jain D, Bia M, Formica R, Mehal W. HCV Response in Patients With End Stage Renal Disease Treated With Combination Pegylated Interferon α-2a and Ribavirin. Journal Of Clinical Gastroenterology 2009, 43: 477-481. PMID: 19142165, PMCID: PMC3715868, DOI: 10.1097/mcg.0b013e318180803a.
- Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysisYarlagadda SG, Coca SG, Formica RN, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrology Dialysis Transplantation 2008, 24: 1039-1047. PMID: 19103734, DOI: 10.1093/ndt/gfn667.
- Medication Errors in the Outpatient Setting: Classification and Root Cause AnalysisFriedman AL, Geoghegan SR, Sowers NM, Kulkarni S, Formica RN. Medication Errors in the Outpatient Setting: Classification and Root Cause Analysis. JAMA Surgery 2007, 142: 278-283. PMID: 17372053, DOI: 10.1001/archsurg.142.3.278.
- Immunosuppressive Therapy Protocols in Kidney Transplantation in AdultsKaramehić J, Lorber M, Formica R, Gavrankapetanović F, Heljić B, Subašić Đ, Zečević L. Immunosuppressive Therapy Protocols in Kidney Transplantation in Adults. Biomolecules And Biomedicine 2006, 6: 43-47. PMID: 16995847, PMCID: PMC7193658, DOI: 10.17305/bjbms.2006.3143.
- A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant periodFormica RN, Friedman AL, Lorber MI, Smith JD, Eisen T, Bia MJ. A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrology Dialysis Transplantation 2006, 21: 1389-1394. PMID: 16431893, DOI: 10.1093/ndt/gfk058.
- Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant periodFormica RN, Friedman AL, Lorber MI, Bia MJ. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period. Transplantation Proceedings 2004, 36: 2675-2678. PMID: 15621121, DOI: 10.1016/j.transproceed.2004.10.013.
Clinical Trials
Conditions | Study Title |
---|---|
HIV/AIDS | Kidney Transplantation in Recipients and Donors with HIV: Long Term Follow up Study |
Diseases of the Kidney & Urinary Tract; HIV/AIDS | HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients |
Immune System; Infectious Diseases | Multicenter, Open Label, Phase 3 Trial of ATA129 for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE Study) |